Argenx SE ADS ADR (ARGX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Tim v. Hauwermeiren |
| Employees: | 650 |
| Web site: | argenx.com |
|
INDUSTRIEPARK ZWIJNAARDE 7, BUILDING C B-9052, ZWIJNAARDE, C9, B-9052
32 (9) 310 34 00
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases. Its lead product candidate is efgartigimod for the. treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy. The company is also developing immunology innovation programs, including cusatuzumab for hematological cancer, as well as high risk MDS.
Please log in first to see chart